NCT06915727 2026-04-01
An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors
Mayo Clinic
Phase 3 Recruiting
Clinical Trials
17 trialsNCT07469202 2026-03-13
CYTALUX Dose Extension Study
On Target Laboratories, LLC
Phase 4 Not yet recruiting
NCT06511037 2026-02-27
PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis
University of California, Irvine
Phase EARLY_PHASE1 Recruiting
NCT07278986 2025-12-12
CYTALUX ISS
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Recruiting
NCT06434909 2025-10-21
CYTALUXâ„¢for the Intraoperative Imaging of Prostate Cancer
Indiana University
Phase 2 Completed
NCT07039526 2025-09-24
Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.
University of Texas Southwestern Medical Center
Phase 2 Recruiting
NCT07124351 2025-09-15
Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUXâ„¢)
Cedars-Sinai Medical Center
Phase 4 Recruiting
NCT06235125 2024-08-22
Cytalux
Ann & Robert H Lurie Children's Hospital of Chicago
Phase 1 Recruiting
NCT02872701 2023-03-24
OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules
On Target Laboratories, LLC
Phase 2 Completed
NCT04241315 2023-03-23
Elucidate
On Target Laboratories, LLC
Phase 3 Completed
NCT02602119 2022-06-28
Intraoperative Imaging of Pulmonary Nodules by OTL38
University of Pennsylvania
Phase 1 Completed
NCT04941378 2022-06-27
OTL38 Injection (OTL38) for Intra-Operative Imaging of Folate Receptor Positive Ovarian Cancer
Abramson Cancer Center at Penn Medicine
Phase 1 Withdrawn
NCT02317705 2022-06-21
Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer
On Target Laboratories, LLC
Phase 2 Completed
NCT03180307 2022-02-04
OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer
On Target Laboratories, LLC
Phase 3 Completed
NCT02852252 2021-06-18
Solid Tumor Cancer Surgery With or Without Intraoperative Imaging: A Registry
University of Pennsylvania
Completed
NCT02645409 2020-02-25
Intraoperative Folate Targeted Fluorescence in Renal Cell Carcinoma
Indiana University
Phase NA Completed
NCT02629549 2019-08-06
Intraoperative Imaging of Pituitary Adenomas by OTL
University of Pennsylvania
Phase 1 Terminated